DE3877647D1 - Physiologisch wirksame produkte, verfahren zur herstellung und zusammensetzung. - Google Patents
Physiologisch wirksame produkte, verfahren zur herstellung und zusammensetzung.Info
- Publication number
- DE3877647D1 DE3877647D1 DE8888810502T DE3877647T DE3877647D1 DE 3877647 D1 DE3877647 D1 DE 3877647D1 DE 8888810502 T DE8888810502 T DE 8888810502T DE 3877647 T DE3877647 T DE 3877647T DE 3877647 D1 DE3877647 D1 DE 3877647D1
- Authority
- DE
- Germany
- Prior art keywords
- composition
- production
- physiologically effective
- effective products
- products
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62184981A JP2651674B2 (ja) | 1987-07-23 | 1987-07-23 | 新規生理活性物質及びその製造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3877647D1 true DE3877647D1 (de) | 1993-03-04 |
DE3877647T2 DE3877647T2 (de) | 1993-05-13 |
Family
ID=16162710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8888810502T Expired - Fee Related DE3877647T2 (de) | 1987-07-23 | 1988-07-21 | Physiologisch wirksame produkte, verfahren zur herstellung und zusammensetzung. |
Country Status (6)
Country | Link |
---|---|
US (1) | US5057324A (de) |
EP (1) | EP0300973B1 (de) |
JP (1) | JP2651674B2 (de) |
AT (1) | ATE84721T1 (de) |
DE (1) | DE3877647T2 (de) |
ES (1) | ES2045182T3 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4985254A (en) * | 1987-11-06 | 1991-01-15 | Nippon Zoki Pharmaceutical Co., Ltd. | Method of treating ischemic diseases |
JP2539674B2 (ja) * | 1987-11-06 | 1996-10-02 | 日本臓器製薬株式会社 | 新規生理活性物質 |
EP0341209B1 (de) * | 1988-04-30 | 1993-09-15 | Nippon Zoki Pharmaceutical Co. Ltd. | Physiologisch wirkende Substanzen, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen davon |
JP2588109B2 (ja) * | 1993-03-19 | 1997-03-05 | 日本臓器製薬株式会社 | 鎮痛剤 |
JP3213832B2 (ja) * | 1993-08-06 | 2001-10-02 | 日本臓器製薬株式会社 | 被検物質の活性測定法 |
JP3213831B2 (ja) * | 1993-08-06 | 2001-10-02 | 日本臓器製薬株式会社 | 被検物質の活性測定方法 |
JP2594222B2 (ja) * | 1993-09-28 | 1997-03-26 | 日本臓器製薬株式会社 | 新規生理活性物質−kf |
JP4033936B2 (ja) * | 1997-01-08 | 2008-01-16 | 日本臓器製薬株式会社 | 一酸化窒素産生抑制剤 |
AU721804B2 (en) * | 1997-01-08 | 2000-07-13 | Nippon Zoki Pharmaceutical Co., Ltd. | Nitrogen monoxide production suppressor |
JPH1180005A (ja) * | 1997-09-12 | 1999-03-23 | Nippon Zoki Pharmaceut Co Ltd | 骨粗鬆症治療剤 |
KR19990044835A (ko) | 1997-11-28 | 1999-06-25 | 고니시 진우에몬 | 생약추출물 |
CN100425692C (zh) * | 1998-06-02 | 2008-10-15 | 株式会社富吉摩托普拉泽兹 | 含有高质量生理活性的家兔发痘组织的制造方法 |
AU763224B2 (en) | 1999-04-15 | 2003-07-17 | Nippon Zoki Pharmaceutical Co., Ltd. | Novel bioactivating substance |
US6726932B2 (en) | 2000-02-18 | 2004-04-27 | Nippon Zoki Pharmaceutical Co., Ltd. | Fatty acid-containing composition |
US6913900B2 (en) * | 2001-08-29 | 2005-07-05 | Nippon Zoki Pharmaceutical Co., Ltd. | Plasma prekallikrein activation and kallikrein production assay |
CN1207005C (zh) * | 2002-10-31 | 2005-06-22 | 威世药业(如皋)有限公司 | 含生物活性物质的兔皮和其用途 |
AU2003280684B2 (en) * | 2002-10-31 | 2009-06-25 | Nippon Zoki Pharmaceutical Co., Ltd. | Remedy for fibromyalgia |
KR101307999B1 (ko) | 2004-12-01 | 2013-09-12 | 니폰 조키 세야쿠 가부시키가이샤 | 건조물 및 그 제조방법 |
US20060134646A1 (en) * | 2004-12-17 | 2006-06-22 | Ansari Aftab A | Method for treatment of HIV infection |
TWI483729B (zh) | 2010-03-11 | 2015-05-11 | Nippon Zoki Pharmaceutical Co | 慢性前列腺炎、間質性膀胱炎及/或排尿障礙之改善或治療劑 |
EP2627343B1 (de) | 2010-10-14 | 2018-01-10 | Nippon Zoki Pharmaceutical Co., Ltd. | Wirkstoffe zur anwendung zur förderung der synthese von kollagen und proteoglykan in bandscheibenzellen |
CA2909234C (en) | 2013-04-30 | 2023-03-14 | Nippon Zoki Pharmaceutical Co., Ltd. | Extracts and preparation thereof from inflamed skins of rabbits inoculated with vaccinia virus |
CN105663166B (zh) * | 2016-03-02 | 2020-04-17 | 中国人民解放军疾病预防控制所 | 特异性抗天花病毒感染模型毒株的生物活性制剂及应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53101515A (en) * | 1977-02-17 | 1978-09-05 | Nippon Zoki Pharmaceutical Co | Medicine having anodyne * sedative and antiallergic activity and production thereof |
JPS54130502A (en) * | 1978-03-31 | 1979-10-09 | Nippon Zoki Pharmaceutical Co | Physiological active substance*its manufacture and medical composition |
JPS5528943A (en) * | 1978-08-22 | 1980-02-29 | Nippon Zoki Pharmaceut Co Ltd | Medicinal composition |
JPS5587724A (en) * | 1978-12-27 | 1980-07-02 | Nippon Zoki Pharmaceut Co Ltd | Selective immune enhancer |
JPS5775991A (en) * | 1980-10-27 | 1982-05-12 | Nippon Zoki Pharmaceut Co Ltd | Novel physiologically active substance jcv-80 |
JPS5777697A (en) * | 1980-11-04 | 1982-05-15 | Nippon Zoki Pharmaceut Co Ltd | Physiologically active substance nsq |
JPS5835117A (ja) * | 1981-08-25 | 1983-03-01 | Nippon Zoki Pharmaceut Co Ltd | 新規生理活性物質nsh |
JPS59118711A (ja) * | 1982-12-25 | 1984-07-09 | Nippon Zoki Pharmaceut Co Ltd | 新規生理活性物質 |
-
1987
- 1987-07-23 JP JP62184981A patent/JP2651674B2/ja not_active Expired - Fee Related
-
1988
- 1988-07-20 US US07/221,975 patent/US5057324A/en not_active Expired - Lifetime
- 1988-07-21 AT AT88810502T patent/ATE84721T1/de not_active IP Right Cessation
- 1988-07-21 DE DE8888810502T patent/DE3877647T2/de not_active Expired - Fee Related
- 1988-07-21 ES ES88810502T patent/ES2045182T3/es not_active Expired - Lifetime
- 1988-07-21 EP EP88810502A patent/EP0300973B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ATE84721T1 (de) | 1993-02-15 |
JP2651674B2 (ja) | 1997-09-10 |
JPS6429389A (en) | 1989-01-31 |
ES2045182T3 (es) | 1994-01-16 |
EP0300973B1 (de) | 1993-01-20 |
US5057324A (en) | 1991-10-15 |
DE3877647T2 (de) | 1993-05-13 |
EP0300973A1 (de) | 1989-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3877647D1 (de) | Physiologisch wirksame produkte, verfahren zur herstellung und zusammensetzung. | |
RU2159761C2 (ru) | Замещенные 4-биарилмасляные или 5-биарилпентановые кислоты или их производные, способы их получения, фармацевтическая композиция и способ лечения | |
DE3876877D1 (de) | Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus. | |
DE69706566D1 (de) | Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit | |
ATE231885T1 (de) | Verwendung von komplement-inhibitoren zur herstellung eines arzneimittels zur prophylaxe und therapie von entzündlichen darm- und hauterkrankungen sowie purpura | |
DE69113386D1 (de) | Herstellung von Medikamenten zur Behandlung von Asthma, unter Verwendung von (S)-Alpha-Fluoromethyl-Histidin und dessen Estern. | |
DE3679128D1 (de) | Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben. | |
DE3688038D1 (de) | Verwendung von buspiron zur herstellung von pharmazeutischen zusammensetzungen zur linderung von krankhaften angst. | |
ATE181237T1 (de) | Substituierte cyclohexan-derivate zur behandlung von krankheiten | |
ATE193442T1 (de) | 3,4-diarylchromane zur behandlung von dermatitis | |
ATE94401T1 (de) | Physiologisch wirkende substanzen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen davon. | |
DE3850154D1 (de) | Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression. | |
DE3581416D1 (de) | Arzneimittel und die verwendung schwerloeslicher calcium- und/oder magnesiumverbindungen zur herstellung eines arzneimittels. | |
ATE246518T1 (de) | Egr-1 zur herstellung eines medikamentes zur behandlung von wunden | |
EP0328924A3 (de) | Thienotriazoldiazepinverbindungen und deren pharmazeutische Anwendungen | |
DE69805305D1 (de) | Verwendung von phanquinon zur behandlung von alzheimer's krankheit | |
ATE252383T1 (de) | Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
PT86032A (de) | Ifosfamid-lyophilisat und verfahren zu dessen herstellung | |
ATE143809T1 (de) | Placentaextrakt und verfahren zu seiner herstellung | |
WO2001014576A8 (en) | Process and intermediates for the preparation of isoxazolecaroxamides and analogues | |
DE3769358D1 (de) | 1-acyl-2,3-dihydro-4(1h)-chinolinon-4-oxim-derivate, verfahren zur herstellung davon, pharmazeutische zusammensetzungen und zwischenprodukte. | |
DE68916777D1 (de) | Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis. | |
ATE297749T1 (de) | Verwendung von peptidischen bradykinin- antagonisten zur herstellung von arzneimitteln | |
DE69610045D1 (de) | Verwendung eines Rohpflanzenextraktes zur Herstellung eines Arzneimittels zur Behandlung von HIV-Infektionen | |
NO20014414L (no) | Farmasöytisk blanding for forhindring eller behandling av sykdom assosiert med et overskudd av IL-12 produksjon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |